Oral GLP-1 weight loss pills could replace injections by March 2026 at $150 monthly, Medicare chief Dr. Mehmet Oz predicted in a FOX Business appearance.
The announcement comes on the heels of a deal with the Trump administration to expand access to weight-loss drugs and reduce ...
Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug ...
Clinicians prescribing GLP-1 agents should ask about sexual function and consider medication review if new anorgasmia appears.
The Combating Counterfeit Pharmaceuticals Act, which would amend the Fentanyl Sanctions Act, is authored by Sens. Tom Cotton ...
Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label, the FDA ...
Alabama Attorney General Steve Marshall says that a Cullman County Circuit Court approved his request for a temporary ...
In an interview with CBS News, FDA Commissioner Dr. Marty Makary explains what went into the decision to drop the most ...
Medpage Today on MSN
Semaglutide's MASH Benefits Extend Beyond Weight Loss
WASHINGTON -- Semaglutide (Wegovy) improved liver inflammation and fibrosis in patients with metabolic dysfunction-associated ...
Scientists found that long-term, low doses of THC reduced inflammation and liver toxicity caused by HIV and antiretroviral ...
The science around hormone therapy to treat menopause has changed a lot since the FDA issued warning labels 20 years ago. Now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback